Annual epidemiological report - European Centre for Disease ...

website health topics pages at http://ecdc.europa.eu/en/healthtopics. .... surveillance, monitoring, early warning of, and combating serious cross border threats to ...
2MB Sizes 3 Downloads 159 Views
SURVEILLANCE REPORT

Annual epidemiological report Antimicrobial resistance and healthcare-associated infections

2014 www.ecdc.europa.eu

ECDC SURVEILLANCE REPORT

Annual epidemiological report Antimicrobial resistance and healthcare-associated infections 2014

This report of the European Centre for Disease Prevention and Control (ECDC) was coordinated by Catalin Albu, Sergio Brusin and Bruno Ciancio.

Contributing authors

Liselotte Diaz Högberg, Klaus Weist, Carl Suetens, Jolanta Griskeviciene, Dominique Monnet and Ole Heuer. In accordance with the Staff Regulations for Officials and Conditions of Employment of Other Servants of the European Union and the ECDC Independence Policy, ECDC staff members shall not, in the performance of their duties, deal with a matter in which, directly or indirectly, they have any personal interest such as to impair their independence.

In order to facilitate more timely publication, this year’s edition of the Annual Epidemiological Report is being first published a disease group at a time and will later be compiled into one comprehensive report. This report presents the epidemiological situation for antimicrobial resistance and healthcare-associated infections as of 2012.

Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological report 2014. Antimicrobial resistance and healthcare-associated infections. Stockholm: ECDC; 2015.

Stockholm, April 2015

© European Centre for Disease Prevention and Control, 2015 Reproduction is authorised, provided the source is acknowledged

ii

SURVEILLANCE REPORT

Annual epidemiological report 2014 – Antimicrobial resistance and healthcare-associated infections

Contents Abbreviations ............................................................................................................................................... iv Introduction .................................................................................................................................................. 1 A note to the reader.................................................................................................................................. 1 Description of methods ............................................................................................................................. 2 Data protection......................................................................................................................................... 4 Antimicrobial resistance and healthcare-associated infections ............................................................................. 5 Antimicrobial resistance ............................................................................................................................. 5 Antimicrobial consumption ....................................................................................................................... 11 Healthcare-associated infections .............................................................................................................. 16

Figures Figure 1. Escherichia coli: percentage (%) of invasive (blood and cerebrospinal fluid) isolates resistant to thirdgeneration cephalosporins, EU/EEA, 2012 ........................................................................................................ 6 Figure 2. Klebsiella pneumoniae: percentage (%) of invasive (blood and cerebrospinal fluid) isolates with combined resistance (resistant to third-generation cephalosporins, fluoroquinolones and aminoglycosides), EU/EEA, 2012 ..... 7 Figure 3. Klebsiella pneumoniae: percentage (%) of invasive (blood and cerebrospinal fluid) isolates resistant to carbapenems, EU/EEA, 2012 ........................................................................................................................... 7 Figure 4. Acinetobacter spp.: percentage (%) of invasive (b